March 15, 2021
Via: CNBCGenMark Diagnostics (GNMK) – GenMark will be bought by Swiss drugmaker Roche for $1.8 billion in cash, or $24.05 per share. Shares of the U.S.-based molecular diagnostic test maker had closed at $18.50 per share on Friday. GenMark surged 29.2% […]
September 22, 2017
Via: Market WatchIt’s no fun being a contrarian when investors are fleeing retail stocks on worries about the damage Amazon.com is doing to this sector. Case in point: Late last May I liked Advance Auto Parts AAP, -1.07% at around $134, on […]